Updated:
Evonik Industries AG
Evonik Industries AG is the specialty chemicals company spun off from RAG AG in 2007, led by CEO Christian Kullmann, employing ~33,000 people.
Evonik Industries AG
Evonik Industries AG is a publicly traded specialty chemicals company headquartered in Essen, Germany. It was formed in 2007 when the industrial conglomerate RAG AG spun off its chemicals, energy, and real estate activities; Evonik went public on the Frankfurt Stock Exchange in 2010. The company remains majority-owned by the RAG-Stiftung, a foundation managing the legacy of Germany's hard-coal mining industry. Evonik's strategy centers on three growth divisions: Specialty Additives, Nutrition & Care, and Smart Materials. The company invests in R&D at a rate of about 5% of sales, targeting innovation in areas like biodegradable plastics, animal nutrition additives, and high-performance polymers for automotive and electronics. Its investment posture is internal — capital expenditures and bolt-on acquisitions, not external asset management. In 2023, Evonik acquired the German biotech firm Synthomer's strategic assets to bolster its healthcare adhesives portfolio. The company employs roughly 33,000 people and operates production sites in 28 countries, with major hubs in Germany, Belgium, the US, China, and Singapore. Evonik also runs a corporate venture capital arm, Evonik Venture Capital, which makes minority investments in startups aligned with its core chemical and materials businesses. In April 2024, Evonik announced a restructuring plan targeting €400 million in annual cost savings by 2026, driven by portfolio streamlining and digitalization. A structural differentiator is Evonik's ownership — the RAG-Stiftung owns about 54% of shares, tying the company's financial performance to Germany's coal-mining legacy fund. This gives Evonik a long-term stable shareholder base but also links its dividend policy to a foundation supporting mining communities. Unlike pure-play chemical companies, Evonik balances industrial cyclicality with a public listing and a state-related anchor investor.
General information
Firm type
other
Year founded
2007
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Essen
Corporate office
Essen, North Rhine-Westphalia, Germany
Principals
Christian Kullmann
Chief Executive Officer (CEO)
Maike Schuh
Chief Financial Officer (CFO)
Sector focus
Frequently asked questions
Who controls Evonik Industries AG?
Evonik is publicly traded on the Frankfurt Stock Exchange, but the RAG-Stiftung, a foundation representing Germany's coal-mining legacy, owns roughly 54% of shares. The remaining free float is held by institutional and retail investors. This gives Evonik a stable, long-term oriented controlling shareholder.
How does Evonik invest its capital?
Evonik reinvests its industrial cash flow into research and development, capital expenditures, and bolt-on acquisitions. It is not an investment firm but a specialty chemicals manufacturer. The company's corporate venture arm, Evonik Venture Capital, makes minority investments in startups developing advanced materials, bio-based chemicals, and digital technologies.
What are Evonik's main business divisions?
Evonik operates through three growth divisions: Specialty Additives (includes additives for paints, coatings, and lubricants), Nutrition & Care (animal nutrition, health ingredients, and pharmaceuticals), and Smart Materials (high-performance polymers for automotive, electronics, and construction). A fourth division, Performance Materials, is being streamlined as part of a restructuring.
Is Evonik related to a family office?
No. Evonik is a publicly traded company with a corporate structure. However, its majority shareholder, the RAG-Stiftung, functions similarly to a foundation with a long-term mandate — managing assets to support Germany's coal-mining transition. The foundation holds a portfolio that includes Evonik shares as its primary asset, but Evonik itself does not operate as a family office.
What geographic markets does Evonik focus on?
Evonik has global operations, with production sites in 28 countries. Its primary markets are Europe, North America, and Asia-Pacific. Major production and innovation hubs include Germany, Belgium, the US, China, and Singapore. The company is expanding in Asia, particularly in China and India, to capture growth in specialty chemicals demand.
What is Evonik's environmental and sustainability strategy?
Evonik has committed to reducing its Scope 1 and 2 greenhouse gas emissions by 25% by 2030 compared to 2021, and aims for climate neutrality by 2050. Its investments focus on energy-efficient processes, renewable feedstocks, and products that enable circular economies — like biodegradable polymers and materials for lightweight vehicles.
Does Evonik invest in external startups or funds?
Yes, through Evonik Venture Capital, which operates as a corporate venture capital arm. The unit makes minority equity investments in early- to growth-stage startups in advanced materials, bio-based chemicals, digital tools, and related fields. It also participates in co-investments with institutional VCs, though it typically focuses on strategic fit rather than pure financial returns.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: